NDC 0007-3372

COREG CR

Carvedilol Phosphate

COREG CR is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Carvedilol Phosphate.

Product ID0007-3372_1f7b1adb-7f45-411b-a45d-784cc79d8031
NDC0007-3372
Product TypeHuman Prescription Drug
Proprietary NameCOREG CR
Generic NameCarvedilol Phosphate
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2007-02-14
Marketing CategoryNDA / NDA
Application NumberNDA022012
Labeler NameGlaxoSmithKline LLC
Substance NameCARVEDILOL PHOSPHATE
Active Ingredient Strength40 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0007-3372-13

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0007-3372-13)
Marketing Start Date2007-02-14
Marketing End Date2023-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0007-3372-13 [00007337213]

COREG CR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA022012
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-02-14

NDC 0007-3372-59 [00007337259]

COREG CR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA022012
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-02-14
Marketing End Date2011-07-22

NDC 0007-3372-61 [00007337261]

COREG CR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA022012
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-08-28
Marketing End Date2014-05-06

Drug Details

Active Ingredients

IngredientStrength
CARVEDILOL PHOSPHATE40 mg/1

OpenFDA Data

SPL SET ID:06400a4c-42b4-440a-92b4-1f47f98ac7ba
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 860516
  • 860532
  • 860512
  • 860510
  • 860524
  • 860522
  • 860518
  • 860534
    • UPC Code
  • 0300073370131
  • 0300073371138
  • 0300073372135
  • 0300073373132

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • Adrenergic beta1-Antagonists [MoA]
    • Adrenergic beta2-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]
    • beta-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "COREG CR" or generic name "Carvedilol Phosphate"

    NDCBrand NameGeneric Name
    68151-5049COREG CRCOREG CR
    68151-5048COREG CRCOREG CR
    68151-5050COREG CRCOREG CR
    68151-5051COREG CRCOREG CR
    0115-1248Carvedilol PhosphateCARVEDILOL PHOSPHATE
    0115-1249Carvedilol PhosphateCARVEDILOL PHOSPHATE
    0115-1250Carvedilol PhosphateCARVEDILOL PHOSPHATE
    0115-1251Carvedilol PhosphateCARVEDILOL PHOSPHATE
    16714-227Carvedilol PhosphateCarvedilol Phosphate
    16714-228Carvedilol PhosphateCarvedilol Phosphate
    0007-3370COREGcarvedilol phosphate
    0007-3371COREGcarvedilol phosphate
    0007-3372COREGcarvedilol phosphate
    0007-3373COREGcarvedilol phosphate
    0007-3383COREGcarvedilol phosphate
    0007-3385COREGcarvedilol phosphate
    0007-3387COREGcarvedilol phosphate
    0007-3388COREGcarvedilol phosphate

    Trademark Results [COREG]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    COREG
    COREG
    74583051 2000337 Live/Registered
    SMITHKLINE BEECHAM LIMITED
    1994-10-06
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.